Inovio’s HPV vaccine demonstrates immunological benefits in RRP

Submitted by admin on May 9, 2023 - 10:42am

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

Inovio announced new data from a Phase I/II trial investigating INO-3107 in patients with HPV-associated recurrent respiratory papillomatosis (RRP).

Search form